Cargando…

Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence

INTRODUCTION: Psychosocial interventions for Alzheimer’s dementia (AD) may increase patients quality of life and overall functioning, while it decreases caregivers burden. Therefore psychotherapies represent an important component of the case management, beside pharmacological approaches. OBJECTIVES...

Descripción completa

Detalles Bibliográficos
Autores principales: Vasile, D., Vasiliu, O., Vasiliu, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475876/
http://dx.doi.org/10.1192/j.eurpsy.2021.1122
_version_ 1784790011560853504
author Vasile, D.
Vasiliu, O.
Vasiliu, D.
author_facet Vasile, D.
Vasiliu, O.
Vasiliu, D.
author_sort Vasile, D.
collection PubMed
description INTRODUCTION: Psychosocial interventions for Alzheimer’s dementia (AD) may increase patients quality of life and overall functioning, while it decreases caregivers burden. Therefore psychotherapies represent an important component of the case management, beside pharmacological approaches. OBJECTIVES: To review the current psychotherapeutic options available for patients diagnosed with AD, that may be added to their ongoing pharmacological treatment. METHODS: A literature review was conducted through main electronic databases, and papers published between January 2000 and August 2020 were included in the analysis. RESULTS: Cognitive stimulation therapy is based on general cognitive abilities training, with an accent over the social interaction, and it has been associated with significant improvement when compared to wait list or standard care. Reminiscence therapy, usually administered in a group format, focuses on past experinces, triggered by photos, newspaper fragments, music tunes etc., and according to a meta-analysis it may increase communicational, cognitive, and affective abilities. Validation therapy is based on a very empathic communication and tries to acknowledge patients perspective over the world, but the data to support its efficacy is limited for AD. Multisensorial stimulation is based on the assumption that stimuli deprivation is involved in the onset of anxiety, restlessness, insomnia etc, and may lead to short-term non-cognitive symptoms. Music therapy, art therapy, and animal-assisted therapy are also indicated, but more trials are needed to confirm their efficacy. CONCLUSIONS: A large number of psychotherapeutic interventions are explored for AD patients, but most of them have low levels of evidence.
format Online
Article
Text
id pubmed-9475876
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94758762022-09-29 Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence Vasile, D. Vasiliu, O. Vasiliu, D. Eur Psychiatry Abstract INTRODUCTION: Psychosocial interventions for Alzheimer’s dementia (AD) may increase patients quality of life and overall functioning, while it decreases caregivers burden. Therefore psychotherapies represent an important component of the case management, beside pharmacological approaches. OBJECTIVES: To review the current psychotherapeutic options available for patients diagnosed with AD, that may be added to their ongoing pharmacological treatment. METHODS: A literature review was conducted through main electronic databases, and papers published between January 2000 and August 2020 were included in the analysis. RESULTS: Cognitive stimulation therapy is based on general cognitive abilities training, with an accent over the social interaction, and it has been associated with significant improvement when compared to wait list or standard care. Reminiscence therapy, usually administered in a group format, focuses on past experinces, triggered by photos, newspaper fragments, music tunes etc., and according to a meta-analysis it may increase communicational, cognitive, and affective abilities. Validation therapy is based on a very empathic communication and tries to acknowledge patients perspective over the world, but the data to support its efficacy is limited for AD. Multisensorial stimulation is based on the assumption that stimuli deprivation is involved in the onset of anxiety, restlessness, insomnia etc, and may lead to short-term non-cognitive symptoms. Music therapy, art therapy, and animal-assisted therapy are also indicated, but more trials are needed to confirm their efficacy. CONCLUSIONS: A large number of psychotherapeutic interventions are explored for AD patients, but most of them have low levels of evidence. Cambridge University Press 2021-08-13 /pmc/articles/PMC9475876/ http://dx.doi.org/10.1192/j.eurpsy.2021.1122 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Vasile, D.
Vasiliu, O.
Vasiliu, D.
Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title_full Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title_fullStr Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title_full_unstemmed Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title_short Psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
title_sort psychotherapies for neurocognitive disorder due to alzheimer’s disease- the current level of evidence
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9475876/
http://dx.doi.org/10.1192/j.eurpsy.2021.1122
work_keys_str_mv AT vasiled psychotherapiesforneurocognitivedisorderduetoalzheimersdiseasethecurrentlevelofevidence
AT vasiliuo psychotherapiesforneurocognitivedisorderduetoalzheimersdiseasethecurrentlevelofevidence
AT vasiliud psychotherapiesforneurocognitivedisorderduetoalzheimersdiseasethecurrentlevelofevidence